- Home
- JBDI vs COSM Comparison
JBDI vs COSM Comparison
Compare JBDI & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBDI
- COSM
- Stock Information
- Founded
- JBDI 1983
- COSM 2009
- Country
- JBDI Singapore
- COSM United States
- Employees
- JBDI N/A
- COSM N/A
- Industry
- JBDI
- COSM Other Pharmaceuticals
- Sector
- JBDI
- COSM Health Care
- Exchange
- JBDI Nasdaq
- COSM Nasdaq
- Market Cap
- JBDI 13.6M
- COSM 13.6M
- IPO Year
- JBDI 2024
- COSM 2013
- Fundamental
- Price
- JBDI $0.58
- COSM $0.58
- Analyst Decision
- JBDI
- COSM
- Analyst Count
- JBDI 0
- COSM 0
- Target Price
- JBDI N/A
- COSM N/A
- AVG Volume (30 Days)
- JBDI 174.7K
- COSM 132.4K
- Earning Date
- JBDI 02-15-2025
- COSM 11-14-2024
- Dividend Yield
- JBDI N/A
- COSM N/A
- EPS Growth
- JBDI N/A
- COSM N/A
- EPS
- JBDI N/A
- COSM N/A
- Revenue
- JBDI $9,394,000.00
- COSM $56,042,109.00
- Revenue This Year
- JBDI N/A
- COSM $4.53
- Revenue Next Year
- JBDI N/A
- COSM $25.00
- P/E Ratio
- JBDI N/A
- COSM N/A
- Revenue Growth
- JBDI N/A
- COSM 13.01
- 52 Week Low
- JBDI $0.51
- COSM $0.47
- 52 Week High
- JBDI $39.41
- COSM $1.65
- Technical
- Relative Strength Index (RSI)
- JBDI N/A
- COSM 27.63
- Support Level
- JBDI N/A
- COSM $0.69
- Resistance Level
- JBDI N/A
- COSM $0.73
- Average True Range (ATR)
- JBDI 0.00
- COSM 0.06
- MACD
- JBDI 0.00
- COSM -0.02
- Stochastic Oscillator
- JBDI 0.00
- COSM 0.00
About JBDI JBDI Holdings Limited Ordinary Shares
JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. Its products include Reconditioned and new steel drums, plastic drums, carboys and IBCs.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.